Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance

被引:849
作者
Albillos, Agustin [1 ,2 ,3 ]
Lario, Margaret [1 ]
Alvarez-Mon, Melchor [1 ,2 ,4 ]
机构
[1] Univ Alcala, Dept Med, Madrid, Spain
[2] Inst Salud Carlos III, CIBERehd, Madrid, Spain
[3] Hosp Univ Ramon & Cajal, Serv Gastroenterol & Hepatol, Madrid, Spain
[4] Hosp Univ Principe Asturias, Serv Immune Dis & Oncol, Madrid, Spain
关键词
Inflammation; Immunodeficiency; Immune response; Lipopolysaccharide; T-helper; T-cytotoxic; ALCOHOLIC LIVER-CIRRHOSIS; NECROSIS-FACTOR-ALPHA; SPONTANEOUS BACTERIAL PERITONITIS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; ACUTE KIDNEY INJURY; PERIPHERAL-BLOOD; SERUM-LEVELS; INFLAMMATORY RESPONSE; SYSTEMIC INFLAMMATION; RECEPTOR ANTAGONIST;
D O I
10.1016/j.jhep.2014.08.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The term cirrhosis-associated immune dysfunction refers to the main syndromic abnormalities of immune function, immunodeficiency and systemic inflammation that are present in cirrhosis. The course of advanced cirrhosis, regardless of its aetiology, is complicated by cirrhosis-associated immune dysfunction and this constitutes the pathophysiological hallmark of an increased susceptibility to bacterial infection, distinctive of the disease. Cirrhosis impairs the homeostatic role of the liver in the systemic immune response. Damage to the reticulo-endothelial system compromises the immune surveillance function of the organ and the reduced hepatic synthesis of proteins, involved in innate immunity and pattern recognition, hinders the bactericidal ability of phagocytic cells. Systemic inflammation, in form of activated circulating immune cells and increased serum levels of pro-inflammatory cytokines, is the result of persistent episodic activation of circulating immune cells from damage-associated molecular patterns, released from necrotic liver cells and, as cirrhosis progresses, from pathogen-associated molecular patterns, released from the leaky gut. Cirrhosis-associated immune dysfunction phenotypes switch from predominantly "pro-inflammatory'' to predominantly "immunodeficient'' in patients with stable ascitic cirrhosis and in patients with severely decompensated cirrhosis and extra-hepatic organ failure (e.g. acute-on-chronic liver failure), respectively. These cirrhosis-associated immune dysfunction phenotypes represent the extremes of a spectrum of reversible dynamic events that take place during the course of cirrhosis. Systemic inflammation can affect the functions of tissue somatic cells and modify the clinical manifestation of cirrhosis. The best characterized example is the contribution of systemic inflammation to the haemodynamic derangement of cirrhosis, which correlates negatively with prognosis. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1385 / 1396
页数:12
相关论文
共 133 条
  • [1] Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites
    Albillos, A
    de-La-Hera, A
    Alvarez-Mon, M
    [J]. LANCET, 2004, 363 (9421) : 1608 - 1610
  • [2] Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis:: amelioration with norfloxacin
    Albillos, A
    de la Hera, A
    Reyes, E
    Monserrat, J
    Muñoz, L
    Nieto, M
    Prieto, A
    Sanz, E
    Alvarez-Mon, M
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 (04) : 624 - 631
  • [3] Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement
    Albillos, A
    de la Hera, A
    González, M
    Moya, JL
    Calleja, JL
    Monserrat, J
    Ruiz-del-Arbol, L
    Alvarez-Mon, M
    [J]. HEPATOLOGY, 2003, 37 (01) : 208 - 217
  • [4] Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis
    Altorjay, Istvan
    Vitalis, Zsuzsanna
    Tornai, Istvan
    Palatka, Karoly
    Kacska, Sandor
    Farkas, Gyula
    Udvardy, Miklos
    Harsfalvi, Jolan
    Dinya, Tamas
    Orosz, Peter
    Lombay, Bela, Jr.
    Par, Gabriella
    Par, Alajos
    Csak, Timea
    Osztovits, Janos
    Szalay, Ferenc
    Csepregi, Antal
    Lakatos, Peter Laszlo
    Papp, Maria
    [J]. JOURNAL OF HEPATOLOGY, 2010, 53 (03) : 484 - 491
  • [5] Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2) Variants Are Genetic Risk Factors for Death and Spontaneous Bacterial Peritonitis in Liver Cirrhosis
    Appenrodt, Beate
    Gruenhage, Frank
    Gentemann, Martin G.
    Thyssen, Lydia
    Sauerbruch, Tilman
    Lammert, Frank
    [J]. HEPATOLOGY, 2010, 51 (04) : 1327 - 1333
  • [6] Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
    Arvaniti, Vasiliki
    D'Amico, Gennaro
    Fede, Giuseppe
    Manousou, Pinelopi
    Tsochatzis, Emmanuel
    Pleguezuelo, Maria
    Burroughs, Andrew Kenneth
    [J]. GASTROENTEROLOGY, 2010, 139 (04) : 1246 - +
  • [7] Bacterial DNA Translocation Is Associated With Systemic Circulatory Abnormalities and Intrahepatic Endothelial Dysfunction in Patients With Cirrhosis
    Bellot, Pablo
    Carlos Garcia-Pagan, Juan
    Frances, Ruben
    Abraldes, Juan G.
    Navasa, Miguel
    Perez-Mateo, Miguel
    Such, Jose
    Bosch, Jaime
    [J]. HEPATOLOGY, 2010, 52 (06) : 2044 - 2052
  • [8] Longitudinal monocyte Human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis
    Berres, Marie-Luise
    Schnyder, Barbara
    Yagmur, Eray
    Inglis, Brett
    Stanzel, Sven
    Tischendorf, Jens J. W.
    Koch, Alexander
    Winograd, Ron
    Trautwein, Christian
    Wasmuth, Hermann E.
    [J]. LIVER INTERNATIONAL, 2009, 29 (04) : 536 - 543
  • [9] Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis
    Berry, Philip A.
    Antoniades, Charalambos G.
    Carey, Ivana
    McPhail, Mark J. W.
    Hussain, Munther J.
    Davies, Edward T.
    Wendon, Julia A.
    Vergani, Diego
    [J]. INTENSIVE CARE MEDICINE, 2011, 37 (03) : 453 - 460
  • [10] Endotoxin tolerance: new mechanisms, molecules and clinical significance
    Biswas, Subhra K.
    Lopez-Collazo, Eduardo
    [J]. TRENDS IN IMMUNOLOGY, 2009, 30 (10) : 475 - 487